Globus Medical (GMED) Other financing activities (2011 - 2026)

Globus Medical (GMED) has 16 years of Other financing activities data on file, last reported at $26.0 million in Q1 2026.

• Quarterly Other financing activities rose 131.32% year-over-year to $26.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $104.5 million (down 11.63% YoY) and the FY2025 annual result came in at $89.8 million, down 18.73% from the prior year.
• Other financing activities retreated to $26.0 million in Q1 2026, from $62.8 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $69.3 million in Q4 2024 to a low of $1.0 million in Q4 2023.
• A 5-year average of $16.5 million and a median of $11.1 million in 2025 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2023 — Other financing activities slumped 93.29% — and 2024, when it soared 6561.83%.
• Tracing GMED's Other financing activities over 5 years: stood at $15.5 million in 2022, then tumbled by 93.29% to $1.0 million in 2023, then soared by 6561.83% to $69.3 million in 2024, then declined by 9.42% to $62.8 million in 2025, then plunged by 58.63% to $26.0 million in 2026.
• The last three Other financing activities figures came in at $26.0 million (Q1 2026), $62.8 million (Q4 2025), and $11.1 million (Q3 2025), per Business Quant data.